P Bosch, M Bond, C Dejaco, C Ponte, SL Mackie… - RMD open, 2023 - rmdopen.bmj.com
Objectives To update the evidence on imaging for diagnosis, monitoring and outcome prediction in large vessel vasculitis (LVV) to inform the 2023 update of the European …
KA Quinn, MA Ahlman, HD Alessi… - Arthritis & …, 2023 - Wiley Online Library
Objective To assess whether vascular activity seen on 18F‐fluorodeoxyglucose–positron emission tomography (FDG‐PET) scan is associated with angiographic change in large …
Arterial wall damage in Takayasu arteritis (TAK) can progress despite immunosuppressive therapy. Vascular fibrosis is more prominent in TAK than in giant cell arteritis (GCA). The …
D Pugh, D Patel, G Macnaught, A Czopek… - Nature …, 2024 - nature.com
Disease-monitoring in large vessel vasculitis (LVV) is challenging. Simultaneous 18F- fluorodeoxyglucose positron emission tomography with magnetic resonance imaging …
Abstract Purpose of Review Large vessel vasculitides (LVVs) are inflammatory conditions of the wall of large-sized arteries, mainly represented by giant cell arteritis (GCA) and …
Takayasu arteritis (TAK) is a less common large vessel vasculitis where histopathology of involved arteries is difficult to access except during open surgical procedures. Assessment …
PTX3 is a prototypic soluble pattern recognition receptor, expressed at sites of inflammation and involved in regulation of the tissue homeostasis. PTX3 systemic levels increase in many …
Giant cell arteritis is the principal form of systemic vasculitis affecting people over 50. Large- vessel involvement, termed large vessel giant cell arteritis, mainly affects the aorta and its …
Coarctation of the aorta (CoA) is a congenital tightening of the proximal descending aorta. Flow quantification can be immensely valuable for an early and accurate diagnosis …